Entry requirements

120 credits in science/engineering/pharmacy including 45 credits in chemistry/chemical engineering/pharmaceutics/biotechnology and 15 credits in cell biology/microbiology. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Learning outcomes

After the completion of the course, participants will be able to:

• analyze and critically assess the advantages of the nanotechnology-based systems compared to traditional treatments,
• explain the physical and chemical principles that enable the implementation of nanotechnology-based treatments in a clinical setting.

Content

The course will dwell on the key principles behind modern nanotechnology-enabled clinical treatments. The core of the course will include real-life examples of products authorised for clinical use, covering the fundamental science behind their respective invention, competitor technologies, synthesis and manufacturing principles, key features and benefits as well as the clinical need that they fulfill. The course can be continuously updated with new examples over time.

The following topics will be covered in the course: Basic principles of nanotechnology. Nanocrystals. Super-paramagnetic iron oxide nanoparticles (SPIONs). Lipid-based nanoparticles. Protein-based nanoparticles. Viral and non-viral vectors for gene delivery. Examples of clinical indications of nanomaterials will include cancer and non-cancer treatments.

Instruction

Lectures and seminars.

Assessment

Active participation in seminars. Written examination.

Other directives

The course aims to enhance the understanding of fundamental nanotechnology-enabled principles realized in the development of real-life products used in clinical applications. The course is particularly suitable for life-long professional development of eligible participants active in the healthcare system.